FO
FCSC

FT Options’s Fibrocell Science Inc. FCSC Stock Holding History

FT Options’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$116K Buy
+7,600
New +$123K 0.17% 93

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

FT Options's FCSC Position: Q3 2017 in Review

FT Options opened a new position in Fibrocell Science Inc. (FCSC) in Q3 2017: 7,600 shares worth $116K. The stake represents 0.17% of the portfolio and ranks #93 among its holdings.

32 funds tracked by Wall St. Rank hold FCSC as of Q3 2017.

  • FT Options held 7,600 shares of Fibrocell Science Inc. worth $116K as of Q3 2017.
  • Fibrocell Science Inc. was a new FT Options position in Q3 2017.
  • Fibrocell Science Inc. made up 0.17% of FT Options's portfolio in Q3 2017, its #93 holding.
  • 32 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.